A Causal Association Between Drug Use and Cognitive Impairment: A Two-Sample Mendelian Randomization Study
Related Experiment Video
Updated: Jan 11, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Bing Yan1, Zhugui Chen1, Dan Yang1
1Department of Anesthesiology, Central People's Hospital of Zhanjiang, Zhanjiang, China.
Introduction:
Observational studies have suggested a link between certain drugs and cognitive impairment. In this study, a two-sample Mendelian randomization (MR) approach was used to investigate the causal relationship between drug use and different types of dementia.
Methods:
We utilized summary data from genome-wide association studies (GWAS) with populations of European ancestry. The primary analysis was conducted using inverse-variance weighted (IVW) methods; MR Egger, weighted median, and weighted model methods were used to validate the results. Horizontal pleiotropy and outlier detection were assessed via MR Egger and MR-PRESSO, respectively; Cochran's Q test evaluated heterogeneity, whereas leave-one-out analyses were used to evaluate the presence of predominant instrumental variables (IVs). Statistical power was calculated using the online tool mRnd to assess the robustness of MR estimates.
Results:
The IVW analysis indicated that antithrombotic agents (odds ratio [OR] = 2.12, 95% confidence interval [CI] = 1.03-4.34, p = 0.04), HMG CoA reductase inhibitors (OR = 1.36, 95% CI = 1.07-1.72, p = 0.01), and salicylic acid and derivatives (OR = 2.77, 95% CI = 1.44-5.32, p = 0.002) are a strong risk factor for dementia with Lewy bodies (DLB); diuretics (OR = 1.13, 95% CI = 1-1.27, p = 0.047) and calcium channel blockers (OR = 1.16, 95% CI = 1.04-1.29, p = 0.007) might be a risk factor for vascular dementia; thyroid preparations (OR = 1.03, 95% CI = 1.01-1.06, p = 0.01), diuretics (OR = 1.06, 95% CI = 1.02-1.11, p = 0.004), and immunosuppressants (OR = 1.07, 95% CI = 1.01-1.12, p = 0.001), are a risk factor for frontotemporal dementia; HMG CoA reductase inhibitors is a risk factor for dementia in Alzheimer disease (OR = 1.32, 95% CI = 1.05-1.65, p = 0.01). Moreover, antihistamines for systemic use showed some causal effect on cognitive performance (p < 0.05). The MR-Egger regression indicated that results were unaffected by horizontal pleiotropy. Moreover, no heterogeneity was detected. However, power analyses revealed that several associations had relatively low statistical power, suggesting that these findings should be interpreted with caution.
Conclusions:
Our findings suggest that certain drugs may causally affect dementia. Larger, well-designed MR studies may help establish the causal status of these dementia risk factors.
More Related Videos
07:30Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Abuse and Addiction: Pharmacological Phenomena
Experimental Designs